controversies about covid-19 and anticancer treatment with immune checkpoint inhibitors. ¬© 2020 Future Medicine Ltd.Since ICI can restore the immune-competence, if on one hand it can be paradoxically needed to develop the cytokine storm characterizing the acute respiratory distress syndrome (ARDS) phase, on the other hand the epidemiological features of SARS-CoV-2 infection lay for a lower probability to affect these patients compared with their chemo-Treated immune-suppressed counterpart.